EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Peri-implantation treatment with TNF-α inhibitor for endometriosis and/or adenomyosis women undergoing frozen-thawed embryo transfer: A retrospective cohort study

Mengqi Liu, Yan Li, Yuan Yuan, Min Jiang, Ping Yin, Dongzi Yang

Journal of Reproductive Immunology · 2025-02 · 167 · 104415

DOI: 10.1016/j.jri.2024.104415 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Reproductive Immunology, 2025-02. Verfasst von Mengqi Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Kapok Zhucheng Medical Clinic, No. 302, No. 9, Huaqiang Road, Tianhe District, Guangzhou 510623, China. Hauptthemen laut MEDLINE: Embryo Transfer, Endometriosis, Adenomyosis, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PROBLEM: Endometriosis and adenomyosis have common pathogenesis and close relationship, with multi-factors involved in related infertility and IVF failure. They lead to anatomical changes, ovarian reserve reduction, endocrine abnormalities, altered endometrial receptivity and immunological dysfunction. Collective evidence indicate that abnormal function of immune cells and secretion of cytokines are closely related to reproductive outcomes among the women. Some studies showed that increased secretion of tumor necrosis factor alpha (TNF-α) led a key role in pro-inflammatory response in women with endometriosis/adenomyosis.TNF-a is embrryotoxic and receptivity impairing. Therefore, immunotherapy is a targeted therapeutic strategy apart from routine treatment. TNF-α inhibitors such as etanercept and adalimumab were shown to reduce the embryotoxic and anti-inflammatory effects to increase IVF pregnancy rates in recurrent implantation failure or endometrioma patient. However, there's no evidence about the use of adalimumab for patients with endometriosis and/or adenomyosis undergoing Frozen embryo transfer(FET). METHOD OF STUDY: A retrospective analysis of 141 women with endometriosis and/or adenomyosis undergoing FET from January 2021 to Jun 2023 was conducted.They were 20-42 years old, with or without previous implantation failure. Endometriosis was diagnosed by laparoscopy during their infertility workup and adenomyosis was confirmed by vaginal ultrasound screening. GnRH agonist and hormone replacement treatment (HRT) or HRT were taken for endometrium preparation according to doctor's evaluation and preference. Before and after embryo transfer, 84 women were treated with Adalimumab and 57 patients were untreated. Implantation rate, clinical pregnancy rate, ongoing pregnancy rate and live birth rate were compared between the two groups. RESULTS: The demographics and baseline characteristics between the two groups were comparable. Stage of embryo transferred and number of embryo transferred were comparable between the two groups (p = 0.227 and p = 0.204 separately). The regimen of endometrium preparation was similar too(p = 0.907). The implantation rate was significantly improved in study group (28.09 % vs 49.18 %, X2=9.515, P = 0.002). The clinical pregnancy rate was much lower in control group comparing with TNF-α inhibitor treatment group (42.11 % vs 60.71 %, X2=4.723, P = 0.029). There was no significant difference between the two groups as for ongoing pregnancy rate (38.60 % vs 52.38 %, X2=2.591, P = 0.107)and live birth rate (36.84 % vs 47.62 %, X2=1.606, P = 0.205). Following adjustment for age, BMI, number of prior failed transfer, stage of embryo transferred in a multiple logistic analysis, patients treated without TNF-α inhibitor had a significant lower CPR (ORadj 0.45, 95 %CI 0.22-0.92, p = 0.029) and a similar probability for OPR (ORadj 0.56, 95 %CI 0.28-1.12) and LBR (ORadj 0.62, 95 %CI 0.31-1.26) as compared with patients with TNF-α inhibitor treatment. However, an obvious trend of improvement of LBR was observed and it's clinical relevant for the patients. CONCLUSION: In women with endometriosis and/or adenomyosis, peri-implantation treatment with TNF-α inhibitor increased implantation rate and clinical pregnancy rate significantly compared with control group in FET cycles. The ongoing pregnancy rate and live birth rate were not significant different, while the difference was clinical relevant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Embryo TransferEndometriosisAdenomyosisTumor Necrosis Factor-alphaAdalimumabInfertility, FemaleTumor Necrosis Factor InhibitorsHumansFemaleAdultRetrospective StudiesPregnancyEmbryo ImplantationPregnancy RateFertilization in VitroYoung AdultEtanerceptCryopreservation

Stichwörter der Autor:innen

AdenomyosisEndometriosisFrozen embryo transferTNF-α inhibitor

Substanzen

Tumor Necrosis Factor-alphaAdalimumabEtanerceptTumor Necrosis Factor Inhibitors

Autor:innen und Institutionen

  • Kapok Zhucheng Medical Clinic, No. 302, No. 9, Huaqiang Road, Tianhe District, Guangzhou 510623, China.
  • Reproductive Center, Reproductive and Genetic Hospital of Kapok, No.61, Jixiang Road, Qionghai, Hainan 571435, China.
  • Guangzhou Kapok Medical Investment Co., Ltd., Room 116 and 117, No. 173, South 2nd Road, Yuncheng, Baiyun District, Guangzhou 510405, China. Electronic address: yinping@mmhts.net.
  • Department of Obstetrics and Gynecology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 107 Yanjiang West Road, Guangzhou City, Guangdong Province 528406, China.. Electronic address: yangdz@mail.sysu.edu.cn.

Zitieren

APA

Liu, M., Li, Y., Yuan, Y., Jiang, M., Yin, P., & Yang, D. (2025). Peri-implantation treatment with TNF-α inhibitor for endometriosis and/or adenomyosis women undergoing frozen-thawed embryo transfer: A retrospective cohort study. Journal of Reproductive Immunology, 167, 104415. https://doi.org/10.1016/j.jri.2024.104415

Vancouver

Liu M, Li Y, Yuan Y, Jiang M, Yin P, Yang D. Peri-implantation treatment with TNF-α inhibitor for endometriosis and/or adenomyosis women undergoing frozen-thawed embryo transfer: A retrospective cohort study. Journal of Reproductive Immunology. 2025;167:104415. doi:10.1016/j.jri.2024.104415

BibTeX
@article{Liu2025,
  author = {Liu, Mengqi and Li, Yan and Yuan, Yuan and Jiang, Min and Yin, Ping and Yang, Dongzi},
  title = {Peri-implantation treatment with TNF-α inhibitor for endometriosis and/or adenomyosis women undergoing frozen-thawed embryo transfer: A retrospective cohort study},
  journal = {Journal of Reproductive Immunology},
  year = {2025},
  volume = {167},
  pages = {104415},
  doi = {10.1016/j.jri.2024.104415}
}
Kostenlos starten →